Subclinical Cardiovascular Disease and Changes in Self-Reported Mobility: Multi-Ethnic Study of Atherosclerosis

Susan A Everson-Rose1, Carlos F Mendes de Leon2, Nicholas S Roetker3

  • 1Department of Medicine, University of Minnesota Medical School, Minneapolis.

Insights

Subclinical cardiovascular disease markers like intimal-medial thickening are linked to slower walking pace in older adults. However, these markers show limited impact on changes in walking speed over time.

Area of Science:

  • Cardiology
  • Gerontology
  • Public Health

Background:

  • Subclinical cardiovascular disease (CVD) is a precursor to clinical CVD.
  • Markers include intimal-medial thickening, coronary artery calcification, and ankle-brachial index.
  • Walking pace and time are indicators of physical function.

Purpose of the Study:

  • To investigate the association between subclinical CVD markers and changes in self-reported walking over time.
  • To determine if baseline CVD markers predict declines in walking pace and time.

Main Methods:

  • Analysis of data from 6,490 Multi-Ethnic Study of Atherosclerosis participants (aged 45-84).
  • Assessment of walking pace and time over 11 years.
  • Linear generalized estimating equation models used to assess associations.

Main Results:

  • Walking pace and time significantly decreased yearly over the 11-year follow-up.
  • Greater intimal-medial thickening was associated with a faster decline in walking pace.
  • Coronary artery calcification was linked to slower walking pace, but not consistently to its decline.
  • Higher ankle-brachial index correlated with faster baseline walking pace but not changes in pace.

Conclusions:

  • Subclinical CVD is associated with slower walking pace in middle-aged and older adults.
  • Subclinical CVD markers have a limited effect on the rate of decline in walking over time.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
650
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
987
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
531
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.6K